Yeon Hee Park

42PUBLICATIONS
238CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Environmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|May 26, 2026
Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer.

|May 19, 2026
Exploratory Analysis of PTEN Deficiency by Immunohistochemistry from the Phase III CAPItello-291 Trial.

|Feb 05, 2026
Refined risk stratification in residual triple-negative breast cancer after neoadjuvant therapy using residual cancer burden class and lymphovascular invasion.

Tae Hoon Lee, Hyunwoo Lee, Jeong Yun Jang

|Jan 30, 2026
Prospective Single-Arm Study of Endocrine Therapies With Ovarian Function Suppression in Premenopausal Node-Positive Early Breast Cancer Patients With Low Genomic Risk (INTERSTELLAR Trial, KBCSG-25).

Sung Gwe Ahn, Sung Hoon Sim, Taewoo Kang

|Jan 19, 2026
Impact of antiemetic prophylaxis on reducing trastuzumab deruxtecan dose modifications in HER2+/HER2-low breast cancer.

Junghoon Shin, Ji-Yeon Kim, Hee Kyung Ahn

|Jan 14, 2026
Oncologic Outcomes by Pathogenic BRCA Mutation Status in Young Luminal Breast Cancer: A Propensity-Matched Cohort.

Woong Ki Park, Seok Jin Nam, Seok Won Kim

Pageof 7

Frequent Collaborators

8 joint publications

Jeong Eon Lee

7 joint publications

Seock-Ah Im

7 joint publications

Ji-Yeon Kim

7 joint publications

Young-Hyuck Im